SCOTUS pharmaceutical case may impact the cost of generic drugs

The Supreme Court debates whether a brand name drug can pay another company to keep a generic version off the market.

Due Diligence’s Carmen Russell-Sluchansky talks with Scott Nelson, Attorney at the Public Citizen Litigation Group, and Diane Bieri of Arnold & Porter LLP:

Part I:

[jwplayer config=”1″ mediaid=”1362″]


Part 2:

[jwplayer config=”1″ mediaid=”1363″]


About Carmen Munir Russell-Sluchansky 360 Articles
Carmen is a multimedia journalist based in Washington, DC whose work has appeared in a variety of outlets including National Geographic, NBC News, the BBC, Asia! Magazine, The China Post, Chicago Tribune and Orlando Sentinel.